Profile

Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.

Former positions of Robert Gundel

CompaniesPositionEnd
PROMIS NEUROSCIENCES, INC. Chief Executive Officer 2015-06-28
SCORPIUS HOLDINGS, INC. Chief Tech/Sci/R&D Officer 2008-12-31
Chief Tech/Sci/R&D Officer 2008-10-31
Chief Tech/Sci/R&D Officer 2007-12-31
Corporate Officer/Principal 2006-12-31
See the detail of Robert Gundel's experience

Training of Robert Gundel

St. Mary's College of California Masters Business Admin
New York Medical College Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Gundel's experience

Connections

25

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
SCORPIUS HOLDINGS, INC.

Health Technology

PROMIS NEUROSCIENCES, INC.

Health Technology

Private companies6

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Chatham Consulting Group, Inc.

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW